Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH ...
Hanmi Semiconductor has increased the price of its thermal compression bonder (TC Bonder; TCB), a critical piece of equipment ...
Quantbot Technologies LP increased its position in shares of Hanmi Financial Co. (NASDAQ:HAFC – Free Report) by 5,858.5% ...
Zacks Investment Research on MSN7d
What Makes Hanmi Financial (HAFC) a New Strong Buy StockInvestors might want to bet on Hanmi Financial (HAFC), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
American Century Companies Inc. boosted its stake in shares of Hanmi Financial Co. (NASDAQ:HAFC – Free Report) by 13.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC.
Hanmi Financial (HAFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). As U.S. markets show signs of ...
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to ...
SEOUL, South Korea, April 2, 2025 /PRNewswire/ -- Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback